Caxton Associates (New York)’s DexCom DXCM Stock Holding History

Caxton Associates (New York)’s Portfolio DXCM Stock Details DXCM Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$23.3M	Buy
2022 Q1	–	Sell
2021 Q4	$1.36M	Buy
2020 Q4	–	Sell
2020 Q3	$396K	Buy
2020 Q2	–	Sell
2020 Q1	$540K	Buy